Estrogen receptor β selective agonists reduce invasiveness of triplenegative breast cancer cells

E-ISSN： 1791-2423|46|2|878-884

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.2, 2015-01, pp. : 878-884

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2147-2150

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of estrogen receptor β in breast cancer

By Saji Shigehira Hirose Makiko Toi Masakazu

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 21-26

Springer Publishing Company

Access to resources Recommend Favorite

GnRH analogs reduce invasiveness of human breast cancer cells

By Alten Julia Fister Stefanie Schulz Hiltrud Viereck Volker Frosch Karl-Heinz Emons Günter Gründker Carsten

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 13-21

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen receptor and breast cancer

By Sommer S. Fuqua S.A.W.

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 339-352

Academic Press

Access to resources Recommend Favorite

Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 481-499

Bentham Science Publishers

Access to resources Recommend Favorite